inclusion criteria: patients willing and able to provide voluntary written informed consent and to follow the protocol specific requirements. male or female patients over 18 years old. patients with positive rt-pcr test for sars-cov-2 in nasopharyngeal or oropharyngeal swabs (sample collected within 7 days prior to enrollment) who are admitted or being admitted to the hospital for a primary diagnosis of covid-19. in the case of female patients of child-bearing potential, a negative blood pregnancy test prior to beginning the therapy. patients intended to be hospitalized to receive soc including dexamethasone treatment for covid-19.

inclusion criteria: patients willing and able to provide voluntary written informed consent and to follow the protocol specific requirements. male or female patients over 18 years old. patients with positive rt-pcr test for sars-cov-2 in nasopharyngeal or oropharyngeal swabs (sample collected within 7 days prior to enrollment) who are admitted or being admitted to the hospital for a primary diagnosis of covid-19. in the case of female patients of child-bearing potential, a negative blood pregnancy test prior to beginning the therapy. patients intended to be hospitalized to receive soc including dexamethasone treatment for covid-19.